1-8 of 8
Aijun Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

In-Class Transition (iCT) of Proteasome Inhibitor-Based Therapy Prolongs Progression-Free Survival in High-Risk Myeloma Patients: A Real-World Chinese Cohort Study

Free
Rong Fu, Hong Yu, Aijun Liu, Rui Hou, Zunmin Zhu, Junling Zhuang, Li Bao, Zhenling Li, Lihong Liu, Luoming Hua, Yanping Ma, Da Gao, ARong Jin, Xiaohui Suo, Wei Yang, Yuansong Bai, Deqiang Zheng, Wenming Chen
Journal: Blood
Blood (2024) 144 (Supplement 1): 7846.
https://doi.org/10.1182/blood-2024-209471
Published: 2024
Journal Articles

Mitoxantrone Hydrochloride Liposome, Proteasome Inhibitors, Pomalidomide and Dexamethasone Regimen in Multiple Myeloma Patients with Extramedullary Plasmacytoma in China

Free
Menghan Liu, Jigang Wang, Haiguo Zhang, Ying Tian, Hongming Huang, Yan Wang, Qing Leng, Wenming Chen, Aijun Liu
Journal: Blood
Blood (2024) 144 (Supplement 1): 7072.
https://doi.org/10.1182/blood-2024-210174
Published: 2024
Journal Articles

Ixazomib, Pomalidomide and Dexamethasone (IxaPD) Pan-Oral Regimen in the Treatment of Refractory and Relapsed Multiple Myeloma

Free
Miao Chen, Hong Yu, Aijun Liu, Wei Wang, Xiaoqi Qin, Ziping Li, Yanping Ma, Wenming Chen, Rong Fu, Junling Zhuang
Journal: Blood
Blood (2024) 144 (Supplement 1): 7038.
https://doi.org/10.1182/blood-2024-210284
Published: 2024
Journal Articles

Carfilzomib, Pomalidomide, Dexamethasone with and without Daratumumab in Relapsed/Refractory Multiple Myeloma: A Multi-Center, Prospective Real World Study in China

Free
Fujing Zhang, Wei Wang, Hua Wang, Wei Wang, Aijun Liu, Weiwei Tian, Xiaoqi Qin, Zhongjun Xia, Junling Zhuang
Journal: Blood
Blood (2024) 144 (Supplement 1): 6985.
https://doi.org/10.1182/blood-2024-209342
Published: 2024
Journal Articles

The Efficacy and Safety of Zanubrutinib, Dexamethasone and or Not Cyclophosphamide Regimen in Symptomatic Waldenstrom Macroglobulinnemia

Free
Aijun Liu, Jin Lu, Yanping Ma, Da Gao, Luoming Hua, Yuechen Zhang, Chuanying Geng, Ying Tian, Yun Leng, Wenming Chen
Journal: Blood
Blood (2023) 142 (Supplement 1): 6699.
https://doi.org/10.1182/blood-2023-189130
Published: 2023
Journal Articles

A Phase 1b Study to Evaluate Safety and Efficacy of IBI188 in Combination with Azacitidine (AZA) As a First-Line Treatment in Subjects with Newly Diagnosed Higher Risk Myelodysplastic Syndrome

Free
Miao Miao, Depei WU, Shuangfeng Xie, Mei Hong, ChunKang Chang, Li Yu, Sujun Gao, Yan Li, Yuhua Li, Zunmin Zhu, Baolin Tang, Bingzong Li, Haiping Yang, Jishi Wang, Ling Qin, Rong Fu, Fei Li, Liangming Ma, Qifa Liu, Xin Du, Zhongxing Jiang, Zhenyu Li, Aijun Liu, Hongyan Tong, Jun Ma, Li Liu, Qingchi Liu, Yajing Xu, Hui Zhou, Yan Wang, Jianlin Chen, Ziru Niu, Mingxia Chen, Zhijian Xiao
Journal: Blood
Blood (2022) 140 (Supplement 1): 4045–4046.
https://doi.org/10.1182/blood-2022-155901
Published: 2022
Journal Articles

Sequential Intravenous to Oral Proteasome Inhibitor Based Regimens for the Treatment of Newly Diagnosed Multiple Myeloma Patients: A Real-World Study

Free
Aijun Liu, Rong Fu, PhD, Zunmin Zhu, Li Bao, MD, Huizheng Bao, Da Gao, MD, Yanping Ma, PhD, Chen Wenming, MD, Hong Yu
Journal: Blood
Blood (2020) 136 (Supplement 1): 38–39.
https://doi.org/10.1182/blood-2020-139064
Published: 2020
Journal Articles

Which Should be Pursued, Cumulative Dose or Dose Intensity: A Real-World Effectiveness Analysis of Bortezomib-Based First Line Treatment for Untreated Multiple Myeloma Patients

Free
Shenmiao Yang, MD, Aijun Liu, MD, Yuping Zhong, MD, Xiaojun Huang, MDPhD, Wenming Chen, MD, Jin Lu
Journal: Blood
Blood (2015) 126 (23): 4247.
https://doi.org/10.1182/blood.V126.23.4247.4247
Published: 2015